Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-05-02 @ 4:17 PM
Study NCT ID:
NCT05145816
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2021-11-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Sponsor:
University of Texas Southwestern Medical Center
Organization: